Literature DB >> 11299318

Pitx3 activates mouse tyrosine hydroxylase promoter via a high-affinity binding site.

M Lebel1, Y Gauthier, A Moreau, J Drouin.   

Abstract

Tyrosine hydroxylase (TH) is the rate-limiting enzyme of dopamine and (nor)adrenaline biosynthesis. Regulation of its gene expression is complex and different regulatory mechanisms appear to be operative in various neuronal lineages. Pitx3, a homeodomain-containing transcription factor, has been cloned from neuronal tissues and, in the CNS, mouse Pitx3 is exclusively expressed in midbrain dopaminergic (MesDA) neurons from embryonic day 11 (E11). TH appears in these neurons at E11.5, consistent with a putative role of Pitx3 in TH transcription. We show that Pitx3 activates the TH promoter through direct interaction with a single high-affinity binding site within the promoter and that this site is sufficient for Pitx3 responsiveness. In contrast, we did not observe an effect of Nurr1, an orphan nuclear receptor essential for normal development of MesDA neurons, on TH promoter activity. Pitx3 activation of TH promoter activity appears to be cell-dependent suggesting that Pitx3 action may be modulated by other(s) regulatory mechanism(s) and factor(s).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299318     DOI: 10.1046/j.1471-4159.2001.00257.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

Review 1.  Midbrain dopaminergic development in vivo and in vitro from embryonic stem cells.

Authors:  Sarah L Maxwell; Meng Li
Journal:  J Anat       Date:  2005-09       Impact factor: 2.610

Review 2.  The role of transcription factor Pitx3 in dopamine neuron development and Parkinson's disease.

Authors:  Jia Li; John A Dani; Weidong Le
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

3.  Functional roles of Nurr1, Pitx3, and Lmx1a in neurogenesis and phenotype specification of dopamine neurons during in vitro differentiation of embryonic stem cells.

Authors:  Sunghoi Hong; Sangmi Chung; Kaka Leung; Insik Hwang; Jisook Moon; Kwang-Soo Kim
Journal:  Stem Cells Dev       Date:  2013-12-04       Impact factor: 3.272

Review 4.  Complex molecular regulation of tyrosine hydroxylase.

Authors:  Izel Tekin; Robert Roskoski; Nurgul Carkaci-Salli; Kent E Vrana
Journal:  J Neural Transm (Vienna)       Date:  2014-05-28       Impact factor: 3.575

5.  Distinct populations of GABAergic neurons in mouse rhombomere 1 express but do not require the homeodomain transcription factor PITX2.

Authors:  Mindy R Waite; Kaia Skaggs; Parisa Kaviany; Jennifer M Skidmore; Frédéric Causeret; James F Martin; Donna M Martin
Journal:  Mol Cell Neurosci       Date:  2011-09-10       Impact factor: 4.314

6.  A MicroRNA feedback circuit in midbrain dopamine neurons.

Authors:  Jongpil Kim; Keiichi Inoue; Jennifer Ishii; William B Vanti; Sergey V Voronov; Elizabeth Murchison; Gregory Hannon; Asa Abeliovich
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

7.  Structure of distress call: implication for specificity and activation of dopaminergic system.

Authors:  Subramanian Mariappan; Wieslaw Bogdanowicz; Hanumanthan Raghuram; Ganapathy Marimuthu; Koilmani Emmanuvel Rajan
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2015-11-26       Impact factor: 1.836

8.  Expression of Tyrosine Hydroxylase is Negatively Regulated Via Prion Protein.

Authors:  Marcio Henrique Mello da Luz; Isaias Glezer; Andre Machado Xavier; Marcelo Alberti Paiva da Silva; Jessica Monteiro Volejnik Pino; Thiago Panaro Zamith; Taynara Fernanda Vieira; Bruno Brito Antonio; Hanna Karen Moreira Antunes; Vilma Regina Martins; Kil Sun Lee
Journal:  Neurochem Res       Date:  2016-03-15       Impact factor: 3.996

Review 9.  Functional diversity of ventral midbrain dopamine and GABAergic neurons.

Authors:  Tatiana M Korotkova; Alexei A Ponomarenko; Ritchie E Brown; Helmut L Haas
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

10.  Future of cell and gene therapies for Parkinson's disease.

Authors:  Ole Isacson; Jeffrey H Kordower
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.